Influence of vitamin C on the absorption and first pass metabolism of propranolol
✍ Scribed by J. P. Gonzalez; R. Calvo; J. M. Rodríguez-Sasiaín; R. Jimenez; C. Aguirre; A. Valdivieso; P. Souich
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 313 KB
- Volume
- 48-48
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
✦ Synopsis
The effect of ascorbic acid on the availability of propranolol has been examined. After oral administration of propranolol 80 mg with or without ascorbic acid pretreatment (2 g), the plasma concentrations and urinary excretion of propranolol and its metabolites, 4-hydroxy-propranolol and propranolol-conjugated, were determined by HPLC. Compared to controls, vitamin C decreased the maximum concentration of propranolol from 463 to 334 nmol • 1-1, and the area under the propranolol concentration-time curve (from 0 to 24 hours) from 3,13 to 1,96 ~tmol • 1-1 h. The time to reach maximum propranolol concentration was increased from 1,9 to 2,7. The total amount of drug recovered in urine has also significantly diminished (from 12,6 to 4,29 mg). No change in elimination rate was observed, indicating that ascorbic acid had affected both the absorption process and the first pass metabolism. The heart-rate decreased less when propranolol was administered with ascorbic acid in comparison to control subjects, although this interaction has little biological importance.
📜 SIMILAR VOLUMES
In order to elucidate the causes of the species differences in the oral bioavailability (BA) between cynomolgus monkeys and humans, the contributions of first-pass metabolism and intestinal absorption were investigated. Typical substrates of cytochrome P450 enzymes, UDP-glucuronosyltransferase enzym
The low and variable bioavailability of cyclosporine has been attributed to poor absorption. However, recent studies have suggested that intestinal first-pass metabolism exerts a significant effect on bioavailability. We describe theory and methods to differentiate the contribution from oral absorpt
A method has been derived for calculating the mean absorption time of an oral drug and its interconversion metabolite which is generated from the drug systemically and presystemically. The method evolves from the convolution integral and requires plasma AUC and AUMC values after separate intravenous